Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Mineralys Therapeutics Inc’s stock clocked out at $13.34, down -5.32% from its previous closing price of $14.09. In other words, the price has decreased by -$5.32 from its previous closing price. On the day, 0.82 million shares were traded.
Ratios:
To gain a deeper understanding of MLYS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.02 and its Current Ratio is at 14.02. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 10, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $30.
On March 07, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $27.Wells Fargo initiated its Overweight rating on March 07, 2023, with a $27 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 13 ’25 when Slingsby Brian Taylor bought 259,259 shares for $13.50 per share. The transaction valued at 3,499,996 led to the insider holds 8,903,838 shares of the business.
Rodman David Malcom sold 11,366 shares of MLYS for $165,185 on Apr 14 ’25. The Chief Medical Officer now owns 111,686 shares after completing the transaction at $14.53 per share. On Apr 11 ’25, another insider, Levy Adam Scott, who serves as the CFO and Secretary of the company, sold 10,757 shares for $12.06 each. As a result, the insider received 129,684 and left with 215,340 shares of the company.
Stock Price History:
Over the past 52 weeks, MLYS has reached a high of $18.38, while it has fallen to a 52-week low of $8.24. The 50-Day Moving Average of the stock is 4.55%, while the 200-Day Moving Average is calculated to be 8.21%.
Shares Statistics:
A total of 49.82M shares are outstanding, with a floating share count of 38.28M. Insiders hold about 40.99% of the company’s shares, while institutions hold 44.70% stake in the company.
